Eye infection
Drug research and approvals for eye infection: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 21, 2026, 52 studies of eye infection are recruiting on ClinicalTrials.gov, and Health Canada has authorized 0 drug trials for it since 2013.
- Recruiting worldwide: 52
- Trials authorized in Canada: 0
- FDA orphan approvals: 0
- EU medicines: 0
- A Clinical Trial Of Tulisokibart In Participants With Active, Non-Infectious Uveitis (MK-7240-019)NCT07861074 · Phase 2 · Merck Sharp & Dohme LLC · starts Nov 4, 2026
- Pain Phenotyping of Rheumatic Diseases - An Observational StudyNCT07829497 · Not reported · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · starts Nov 9, 2026
- PANDA-ASOCT: Paediatric Anterior Uveitis Detection With Automated Image Analysis Using ASOCTNCT07813598 · Not reported · Sheffield Children's NHS Foundation Trust · starts Sep 9, 2026
- Expanding Access to Preventive Chemotherapy Among Mobile and Migrant PopulationsNCT07707817 · Not applicable · Uwemedimo Friday Ekpo · starts Jul 1, 2026
- Evaluation of Safety and Efficacy of Autologous LB-DTK-CMV in Patients With Antiviral-Resistant and Refractory…NCT07679412 · Not applicable · LucasBio · starts Apr 27, 2026
- Cohort Study on Neuroimmune Diseases in the Reproductive AgeNCT07653984 · Not reported · Third Affiliated Hospital, Sun Yat-Sen University · starts Apr 21, 2024
- Development of a Mobile Terminal-Based Intelligent Detection System for Multiple Anterior Segment Diseases of the EyeNCT07634913 · Not reported · Zhongshan Ophthalmic Center, Sun Yat-sen University · starts Dec 12, 2023
- Safety and Efficacy of SUM-191 for Patients With Bacterial ConjunctivitisNCT07565103 · Phase 1 / Phase 2 · Senju USA, Inc. · starts Jun 25, 2026
- A Phase II Clinical Trial to Evaluate the Efficacy and Safety of FXS5626 in Patients With NIUNCT07552012 · Phase 2 · Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. · starts Jan 29, 2026
How its trials ended
34 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrongOf the 5 whose ending is known, 80% met their primary endpoint, 0% missed it and 20% stopped early.
- Completed, result not reported1853%
- Status unknown618%
- Ongoing515%
- Met its primary endpoint412%
- Stopped: enrollment or feasibility13%
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA